| First-line chemotherapy with planned sequential administration of cisplatin/gemcitabine followed by docetaxel in elderly 'unfrail' patients with advanced non-small-cell lung cancer: a multicenter phase II study. | |
| | |
MedLine Citation:
|
PMID: 22767317 Owner: NLM Status: Publisher |
Abstract/OtherAbstract:
|
PURPOSE: The role of cisplatin in the first-line treatment for elderly advanced non-small-cell lung cancer is not completely defined. We previously reported in this subset of patients an interesting efficacy and tolerability of a sequential schedule of gemcitabine followed by docetaxel. METHODS: Patients aged ≥70 years and with Eastern Cooperative Oncology Group performance status 0 or 1 received cisplatin 60 mg/m(2) on Day 1 and gemcitabine 1,000 mg/m(2) on Day 1 and 8 every 3 weeks for 3 courses followed by 3 courses of docetaxel 37.5 mg/m(2) on Day 1 and 8 every 3 weeks, provided there was no evidence of disease progression. Patients were excluded if considered 'frail' according to the Multidimensional Geriatric Assessment. The main objective of the study was the 4-month progression-free survival rate. Simon's two-stage minimax design was applied to calculate the sample size. RESULTS: After 30 patients were enroled into the study, the 4-month progression-free survival rate was 53.3 % and the study was closed at the first stage for futility; the overall response rate was 16.7 %; the median time to progression and median duration of survival were 5.1 and 8.6 months, respectively; the 1-year survival rate was 30 %. CONCLUSION: The incorporation of cisplatin in a sequential schedule of gemcitabine followed by docetaxel is feasible but did not yield a substantial advantage to deserve further investigations. |
| | |
Authors:
|
C Tibaldi; A Camerini; A D'Incecco; E Vasile; A Fabbri; D Amoroso; F Cappuzzo |
Related Documents
:
|
22466667 - Prognostic significance of antithrombin iii levels for outcomes in patients with hepato... 22684897 - Phase ii study of chop-gr therapy in diffuse large b-cell lymphoma. 22495317 - Relevant impact of central pathology review on nodal classification in individual breas... 22306907 - Autologous cytokine-induced killer cell transfusion in combination with gemcitabine plu... 21487387 - What can molecular pathology contribute to the management of renal cell carcinoma? 17625457 - Gastric metastases from conjunctival melanoma. |
Publication Detail:
|
Type: JOURNAL ARTICLE Date: 2012-7-6 |
Journal Detail:
|
Title: Journal of cancer research and clinical oncology Volume: - ISSN: 1432-1335 ISO Abbreviation: - Publication Date: 2012 Jul |
Date Detail:
|
Created Date: 2012-7-6 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 7902060 Medline TA: J Cancer Res Clin Oncol Country: - |
Other Details:
|
Languages: ENG Pagination: - Citation Subset: - |
Affiliation:
|
Division of Oncology, Department of Oncology, Civil Hospital, viale Alfieri 36, 57100, Livorno, Italy, tiby@katamail.com. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Hepatitis B virus infection and risk of lymphoma: results of a serological analysis within the Europ...
Next Document: Recovery Comparison of Two Virus Concentration Methods from Wastewater Using Cell Culture and Real-T...